HomeCountryEuropeCorteva Agriscience’s upcoming Centre of Seed Applied Technologies to help farmers adapt better

Corteva Agriscience’s upcoming Centre of Seed Applied Technologies to help farmers adapt better

ag-leaders-connectivity-simplifies-unloading-on-the-go-for-grain-cart-operators
source-public domain

The Center in Aussonne is the first in Europe and the third worldwide. Expected to be operational in the first half of 2022 

 

 Corteva Agriscience has begun building a new Center of Seed Applied Technologies (CSAT) in south west France, with the goal of helping Europe’s farmers get their crops off to the best start and achieve a successful harvest. 

The Center in Aussonne is the first in Europe and the third worldwide. Expected to be operational in the first half of 2022, it will focus on service development, with strong scientific investment that will be part of new seed treatment solutions to help farmers meet the challenges of a changing agricultural sector.

Corteva Agriscience also offers a suite of Seed Applied Technology (SAT) solutions, which involve treating the seed, including Lumiposa™ and Lumivia™ for insecticide seed treatment, Lumisena™ and Lumiflex™ for fungicide seed treatment control, and Lumidapt, a seed applied growth nutrition for all hybrid crops.

CSATs act as a laboratory, testing centre and seed treatment plant, with rigorous processes in place for the discovery, formulation and real-world testing of seed applied technologies. This process enables seed treatments to protect and perform to solve on-farm challenges, delivering value for growers.

  “Corteva Agriscience is committed to innovation. That’s why we are investing almost €5m in this project as part of efforts to strengthen our seed offering. We are a company focused on those who produce and those who consume, and this Center will help farmers boost productivity while meeting consumer demand for a more sustainable agriculture”, said Andre Negreiros, Seed Applied Technologies Leader, Europe for Corteva Agriscience.

 

Share

No comments

leave a comment